To see the other types of publications on this topic, follow the link: Hepatitis B.

Journal articles on the topic 'Hepatitis B'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Hepatitis B.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Jyoti, Ranjan Behera, Ranjan Mallick Manas, Kumar Jena Sanjaya, Ranjan Barik Rashmi, Roy Debashisha, and Kumar Mohanty Anil. "Efficacy of Hepatitis B Immunoglobulin and Hepatitis B Vaccine in Prevention of Perinatal Transmission of Hepatitis B." International Journal of Pharmaceutical and Clinical Research 15, no. 11 (2023): 232–38. https://doi.org/10.5281/zenodo.11214130.

Full text
Abstract:
<strong>Introduction:&nbsp;</strong>Hepatitis B is a major global health problem and is a most serious type of viral hepatitis, which puts the people at high risk of death from cirrhosis of the liver and liver cancer. Approximately 30% of the world&rsquo;s population, or about 2 billion persons, have serological evidence of either current or past infection with hepatitis B virus. Most people in China and India become infected with HBV during childhood. India has intermediate endemicity of Hepatitis B, with Hepatitis B surface antigen (HBsAg) prevalence between 2% and 7% among populations studi
APA, Harvard, Vancouver, ISO, and other styles
2

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Full text
Abstract:
Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was
APA, Harvard, Vancouver, ISO, and other styles
3

Jain, Ravi, and Ashok Yadav. "Hepatitis B Versus Hepatitis C in Blood Donors." Annals of Applied Bio-Sciences 4, no. 1 (2017): A8—A13. http://dx.doi.org/10.21276/aabs.2017.1306.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Billah, Mustansar, Syed Muhammad Raza Shah, and Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C." Professional Medical Journal 25, no. 08 (2018): 1245–51. http://dx.doi.org/10.29309/tpmj/18.4766.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tobokalova, S. T., D. S. Bekenova, G. M. Zairova, Z. Sh Nurmatov, Zh N. Nazarbaeva, and Zh T. Aytieva. "Epidemiological features of acute and chronic hepatitis B in the Kyrgyz Republic over the 20-year period (1997-2017)." Kazan medical journal 99, no. 6 (2018): 986–93. http://dx.doi.org/10.17816/kmj2018-986.

Full text
Abstract:
Aim. To determine epidemiological features of acute and chronic viral hepatitis B in the Kyrgyz Republic over the period 1997-2017. Меthоds. Analysis was performed on data bases of the National accounting forms on treated cases of acute and chronic hepatitis B cumulated by the Medical Information Centre of the Ministry of Health of Kyrgyz Republic for the period of 1997 to 2017 as well as 384 medical records of patients with chronic hepatitis B treated in the Hepatologic Centre “Tsadmir”. Results. In the Kyrgyz Republic among all acute cases of acute viral hepatitides, hepatitis A comprises 60
APA, Harvard, Vancouver, ISO, and other styles
6

DAUD, SEEMA, IRAM MANZOOR, and NOREEN RAHAT HASHMI. "PREVENTION OF HEPATITIS B." Professional Medical Journal 14, no. 04 (2007): 634–38. http://dx.doi.org/10.29309/tpmj/2007.14.04.4829.

Full text
Abstract:
Objective: To assess the knowledge and practice of first year MBBS students, for the prevention ofHepatitis B. Design: Descriptive study. Place and Duration of study: The study was conducted at Lahore Medical &amp;Dental College, Lahore. The data was collected in two weeks in December, 2006. Methodology: A total of 50 studentswere recruited using a non probability random sampling technique, through the lottery method. A pre-tested structuredquestionnaire was administered to collect information about the knowledge and practice of students about theprevention of hepatitis B. Data was presented i
APA, Harvard, Vancouver, ISO, and other styles
7

Cano Pina, MB, CM Águila Gordo, P. Dabán López, MP Chas Garibaldi, and B. Mirón Pozo. "New therapeutic approaches in Hepatitis B and Hepatitis D." Revista Andaluza de Patología Digestiva 46, no. 6 (2024): 607–9. http://dx.doi.org/10.37352/2023466.3.

Full text
Abstract:
Resumen La perforación del tracto gastrointestinal (GI) por ingesta de cuerpos extraños (huesos, palillos dentales, dentaduras, etc.) es poco prevalente, su diagnóstico es difícil y tardío principalmente debido a que los pacientes no suelen recordar la ingesta de los mismos. A nivel radiológico supone igualmente un reto, pues suelen ser objetos sutiles no visibles en radiografías, siendo la prueba de elección la TC. Ante una sospecha clínica o radiológica de perforación por cuerpo extraño, el tratamiento quirúrgico y antibiótico debe llevarse a cabo lo antes posible. Presentamos un caso clínic
APA, Harvard, Vancouver, ISO, and other styles
8

Estévez Escobar, M. "New therapeutic approaches in Hepatitis B and Hepatitis D." Revista Andaluza de Patología Digestiva 46, no. 5 (2023): 258–68. http://dx.doi.org/10.37352/2023465.3.

Full text
Abstract:
Resumen El virus de la hepatitis B y el virus de la hepatitis D ocasionan un espectro variable de enfermedades hepáticas, desde cuadros asintomáticos hasta hepatitis fulminante o hepatitis crónica. Debido a que, en su forma crónica, la enfermedad puede tener consecuencias fatales sobre el huésped por desarrollo de cirrosis, disfunción hepática y desarrollo de hepatocarcinoma, es importante el diagnóstico precoz para iniciar un tratamiento que cambie la historia natural de la enfermedad, mejorando así el pronóstico del sujeto. En la actual revisión, se recorren las opciones disponibles de trata
APA, Harvard, Vancouver, ISO, and other styles
9

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes, and Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento." Revista de Patologia do Tocantins 4, no. 3 (2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Full text
Abstract:
INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sa
APA, Harvard, Vancouver, ISO, and other styles
10

Nayak, Akshatha P., Insha Firoz, Ravindra Prabhu, Jayanth Nayak, Veena NK, and Megha Nagaraj Nayak. "Development of Immunity to Hepatitis B Virus Following Hepatitis B Vaccination in Hemodialysis Patient." Annals of International Medical and Dental Research 9, no. 2 (2023): 20–23. http://dx.doi.org/10.53339/aimdr.2023.9.2.4.

Full text
Abstract:
Background: Hepatitis B infection is common in Dialysis population. Hemodialysis patients have high risk of hepatitis B virus transmission not only due to frequent blood or blood product transmission, decreased response to Hepatitis B vaccine and length on hemodialysis but also due to their immunosuppressed state. Hepatitis B vaccination has the potential to reduce the risk of HBsAg infection in dialysis units. Effective vaccination, blood donor screening, the use of erythropoietin and the isolation of HBV carriers have successfully regulated HBV infection in hemodialysis units (1). This study
APA, Harvard, Vancouver, ISO, and other styles
11

Suryani, Siti, and Tatag Mulyanto. "EFEKTIVITAS PENGGUNAAN MEDIA LEAFLET TERHADAP PENGETAHUAN TENTANG PENYAKIT HEPATITIS B PADA IBU HAMIL." Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing) 9, no. 4 (2023): 332–39. http://dx.doi.org/10.33023/jikep.v9i4.1652.

Full text
Abstract:
Pendahuluan: WHO menyebutkan lebih dari 350 juta orang di dunia hidup bersama hepatitis dengan tipe yang berbeda-beda, dan sekitar 296 juta orang yang hidup dengan hepatitis B, yang sebagian besar tinggal di Asia dan Afrika. Data Riskesdas 2018 menunjukkan bahwa Indonesia menempati urutan pertama penyandang penyakit hepatitis B di Asia Tenggara dengan Prevalensi Virus Hepatitis B di Indonesia berkisar 7,1%. Berdasarkan data Kementerian Kesehatan, di tahun 2021 sebanyak 2.946.013 ibu hamil telah dideteksi dini dan diketahui, sebanyak 1,61% ibu hamil terdeteksi positif terinfeksi hepatitis B. Ti
APA, Harvard, Vancouver, ISO, and other styles
12

Pradip, Bhaumik, and Dutta Kumar Pranab. "COMMUNITY BASED MODEL OF HEPATITIS B ELIMINATION IN TRIPURA, NORTH EAST INDIA." International Journal of Advanced Research 12, no. 01 (2024): 1268–71. http://dx.doi.org/10.21474/ijar01/18245.

Full text
Abstract:
Liver can be affected by various virus like Hepatitis A, B, C, D, E. Hepatitiss B and C are blood borne and can cause chronic complications leading to chronic liver disease, cirrhosis and hepatocellular carcinoma. In 1984 Taiwan launched first universal vaccination against Hepatitis B with plasma derived vaccine and they could reduce the burden significantly with in a short period. In 1987 recombinant DNA vaccine become available and hepatitis B vaccination became a target area but the the program did not received proper momentum. A science based social orbanisation, Hepatitis Foundation of Tr
APA, Harvard, Vancouver, ISO, and other styles
13

Haider, Rehan, Asghar Mehdi, Geetha Kumari Das, Zameer Ahmed, and Sambreen Zameer. "Hepatitis B." International Journal of Social Health 3, no. 9 (2024): 555–67. http://dx.doi.org/10.58860/ijsh.v3i9.234.

Full text
Abstract:
Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV), primarily affecting the liver and leading to both acute and chronic disease. With over 250 million individuals suffering from chronic Hepatitis B, it poses a significant global health challenge, being a leading cause of liver cirrhosis, liver failure, and hepatocellular carcinoma. This study aims to elucidate the transmission pathways, treatment options, and necessary public health strategies for Hepatitis B. We analyze the modes of transmission, which include contact with infectious body fluids—primarily through perinatal
APA, Harvard, Vancouver, ISO, and other styles
14

Huma Qureshi, Saeed Akhter, Hassan Mahmood, et al. "Overview of Hepatitis C Elimination Efforts in Pakistan and the Launch of Prime Minister’s Programme for the Elimination of Hepatitis C." Journal of the Pakistan Medical Association 74, no. 12 (2024): 2188–90. http://dx.doi.org/10.47391/jpma.24-97.

Full text
Abstract:
Hepatitis B and C are serious viral infections that cancause liver damage and death. According to the WorldHealth Organization (WHO), there are currently 2.8 millionpeople living with hepatitis B in Pakistan, and 9.8 millionpeople living with hepatitis C.1 These numbers representa significant burden of disease for the country. Thecurrent prevalence of hepatitis B in Pakistan is 1.1%,which corresponds to one-quarter of the burden of thedisease in the Eastern Mediterranean region.1 Theprevalence of hepatitis C is 7.5%, which is the highest inthe world. Almost 37,000 people die each year in Pakis
APA, Harvard, Vancouver, ISO, and other styles
15

Shahbaz, Tazeem, Ghulam Farid, Raja Sajjad Asghar, and Abdul Rashid. "HEPATITIS B AND C." Professional Medical Journal 22, no. 11 (2015): 1383–89. http://dx.doi.org/10.29309/tpmj/2015.22.11.859.

Full text
Abstract:
Background and Aims: The working conditions of Health care workers (HCW’S)expose them for a constant threat of contracting and spreading hepatitis B (HBV) and C virus(HCV) not only to their patients but family members as well. The aim of this study was to assessthe knowledge and attitude toward hepatitis B and C infection among the health-care workersand correlate the level of awareness to their behavior towards prevention of the disease. StudySettings: The study was conducted in Rashid Latif medical college and its two affiliated hospitals(Arif memorial teaching hospital and Hameed Latif Hosp
APA, Harvard, Vancouver, ISO, and other styles
16

Cottone, James A. "Hepatitis B." Dental Clinics of North America 35, no. 2 (1991): 269–82. http://dx.doi.org/10.1016/s0011-8532(22)01397-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Brody, Herb. "Hepatitis B." Nature 603, no. 7903 (2022): S45. http://dx.doi.org/10.1038/d41586-022-00811-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Kuznetsov, N. I. "HEPATITIS B." Russian Family Doctor 16, no. 4 (2012): 13. http://dx.doi.org/10.17816/rfd2012413-18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Pastorek, Joseph G. "Hepatitis B." Obstetrics and Gynecology Clinics of North America 16, no. 3 (1989): 645–57. http://dx.doi.org/10.1016/s0889-8545(21)00413-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Badell, Martina L. "Hepatitis B." Obstetrics & Gynecology 139, no. 3 (2022): 355–56. http://dx.doi.org/10.1097/aog.0000000000004694.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

SHIMIZU, MASARU. "Hepatitis B." Journal of the Japan Society of Blood Transfusion 31, no. 3 (1985): 207–12. http://dx.doi.org/10.3925/jjtc1958.31.207.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Banerji, Orijit. "Hepatitis B." InnovAiT: Education and inspiration for general practice 6, no. 12 (2013): 790–800. http://dx.doi.org/10.1177/1755738013509606.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

BATE, R. G., and S. J. BOLLIPO. "Hepatitis B." Drug and Alcohol Review 15, no. 3 (1996): 289–305. http://dx.doi.org/10.1080/09595239600186031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

TRAN, TRAM T. "Hepatitis B." Clinical Obstetrics and Gynecology 55, no. 2 (2012): 541–49. http://dx.doi.org/10.1097/grf.0b013e318251097a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Howell, Karen. "Hepatitis B." Practice Nursing 12, no. 3 (2001): 114–15. http://dx.doi.org/10.12968/pnur.2001.12.3.4442.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Driver, Carolyn. "Hepatitis B." Practice Nursing 14, no. 7 (2003): 312–15. http://dx.doi.org/10.12968/pnur.2003.14.7.11451.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Evans, Norma. "Hepatitis B." Practice Nursing 17, no. 5 (2006): 248–53. http://dx.doi.org/10.12968/pnur.2006.17.5.21038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Cornberg, Markus, and Michael Manns. "Hepatitis B." Gastroenterologie up2date 5, no. 01 (2009): 35–52. http://dx.doi.org/10.1055/s-0029-1214525.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Mutimer, David J., and Ye Htun Oo. "Hepatitis B." Medicine 39, no. 9 (2011): 545–49. http://dx.doi.org/10.1016/j.mpmed.2011.06.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Befeler, Alex S., and Adrian M. Di Bisceglie. "HEPATITIS B." Infectious Disease Clinics of North America 14, no. 3 (2000): 617–32. http://dx.doi.org/10.1016/s0891-5520(05)70124-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Dehesa-Violante, M. "Hepatitis B." Revista de Gastroenterología de México 78 (August 2013): 90–92. http://dx.doi.org/10.1016/j.rgmx.2013.06.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

TRAN, T. "Hepatitis B." Clinics in Liver Disease 8, no. 2 (2004): xi—xii. http://dx.doi.org/10.1016/s1089-3261(04)00024-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Ng, Vicky Lee, and William F. Balistreri. "HEPATITIS B." Clinics in Liver Disease 3, no. 2 (1999): 267–90. http://dx.doi.org/10.1016/s1089-3261(05)70068-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Osborn, Thomas R. "HEPATITIS B." Journal of the American Dental Association 145, no. 3 (2014): 230–32. http://dx.doi.org/10.1016/s0002-8177(14)60050-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Koff, Raymond S. "Hepatitis B." Gastroenterology 90, no. 4 (1986): 1093. http://dx.doi.org/10.1016/0016-5085(86)90903-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Weisberg, Susan Shoshana. "Hepatitis B." Disease-a-Month 53, no. 9 (2007): 453–58. http://dx.doi.org/10.1016/j.disamonth.2007.09.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Bertoletti, Antonio, and Laura Rivino. "Hepatitis B." Current Opinion in Infectious Diseases 27, no. 6 (2014): 528–34. http://dx.doi.org/10.1097/qco.0000000000000110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Krishnamoorthy, Thinesh Lee, and David Mutimer. "Hepatitis B." Current Opinion in Infectious Diseases 28, no. 6 (2015): 557–62. http://dx.doi.org/10.1097/qco.0000000000000209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Spyrou, Elias, Coleman I. Smith, and Marc G. Ghany. "Hepatitis B." Gastroenterology Clinics of North America 49, no. 2 (2020): 215–38. http://dx.doi.org/10.1016/j.gtc.2020.01.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Lin, Chih-Lin, and Jia-Horng Kao. "Hepatitis B." Gastroenterology Clinics of North America 49, no. 2 (2020): 201–14. http://dx.doi.org/10.1016/j.gtc.2020.01.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Caulfield, Maureen. "Hepatitis B." Clinical Pediatrics 32, no. 7 (1993): 443–44. http://dx.doi.org/10.1177/000992289303200710.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Aramaki, Takumi. "Hepatitis B." Journal of Nippon Medical School 53, no. 6 (1986): 605–8. http://dx.doi.org/10.1272/jnms1923.53.605.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Abbrederis, Susanne, and Wolfgang Vogel. "Hepatitis B." Wiener klinische Wochenschrift Education 4, no. 1 (2009): 43–55. http://dx.doi.org/10.1007/s11812-009-0051-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Jonkers, Aliëtte. "Hepatitis B." Nursing 26, no. 4 (2020): 39–45. http://dx.doi.org/10.1007/s41193-020-0058-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Gerety, Robert J. "Hepatitis B." Current Problems in Pediatrics 17, no. 5 (1987): 309–26. http://dx.doi.org/10.1016/0045-9380(87)90014-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Weakley, Tiffany, and K. Rajender Reddy. "Hepatitis B." Current Treatment Options in Gastroenterology 2, no. 6 (1999): 463–72. http://dx.doi.org/10.1007/s11938-999-0050-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Torpy, Janet M. "Hepatitis B." JAMA 305, no. 14 (2011): 1500. http://dx.doi.org/10.1001/jama.305.14.1500.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Hoofnagle, Jay H. "Hepatitis B." Hepatology 42, no. 4 (2005): 748. http://dx.doi.org/10.1002/hep.20890.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Rashid, MH, MA Alim, MMR Khan, et al. "Hepatitis B e Antigen–Negative Chronic Hepatitis B." TAJ: Journal of Teachers Association 25 (November 28, 2018): 90–96. http://dx.doi.org/10.3329/taj.v25i0.37567.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

DE COCK, KEVIN M. "Hepatitis B Virus DNA in Fulminant Hepatitis B." Annals of Internal Medicine 105, no. 4 (1986): 546. http://dx.doi.org/10.7326/0003-4819-105-4-546.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!